Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sarecycline Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 214,000Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Paratek Announces License Grant to Almirall SEYSARA® for Greater China Region
    Paratek Announces License Grant to Almirall SEYSARA® for Greater China Region

    24 Feb 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/02/24/1989107/0/en/Paratek-Announces-License-Grant-to-Almirall-for-SEYSARA-sarecycline-for-Greater-China-Region.html

    GLOBENEWSWIRE
    24 Feb 2020
    Share Share
    Almirall LLC Announces Long-Term Safety Data For The Use Of Seysara
    Almirall LLC Announces Long-Term Safety Data For The Use Of Seysara

    06 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/almirall-llc-announces-the-publication-of-long-term-safety-data-for-the-use-of-seysara-sarecycline-tablets-in-patients-9-years-of-age-and-older-300970843.html

    PR NEWSWIRE
    06 Dec 2019
    Share Share
    Why Barnes & Noble, Paratek Pharmaceuticals, and Hortonworks Jumped Today
    Why Barnes & Noble, Paratek Pharmaceuticals, and Hortonworks Jumped Today

    04 Oct 2018

    // Dan Caplinger

    https://www.fool.com/investing/2018/10/04/why-barnes-noble-paratek-pharmaceuticals-and-horto.aspx

    Dan Caplinger
    04 Oct 2018
    Share Share
    Paratek enters commercial stage with 2 FDA antibiotics nods
    Paratek enters commercial stage with 2 FDA antibiotics nods

    03 Oct 2018

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/marketing/2-paratek-antibiotics-win-fda-nods-one-slated-for-500m-peak-sales

    Angus Liu FIERCE PHARMA
    03 Oct 2018
    Share Share
    Green light for acne drug Seysara in the US
    Green light for acne drug Seysara in the US

    03 Oct 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/green_light_for_acne_drug_seysara_in_the_us_1254328

    Selina McKee PHARMA TIMES
    03 Oct 2018
    Share Share
    FDA Approves SEYSARA (Sarecycline) for Inflammatory Lesions of Acne Vulgaris
    FDA Approves SEYSARA (Sarecycline) for Inflammatory Lesions of Acne Vulgaris

    01 Oct 2018

    //

    https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209521s000lbl.pdf

    01 Oct 2018
    Share Share